Fecal Microbiota Transplantation (FMT) Market is expected to reach US$ 1.83 Bn. at a CAGR of 4.9% during the forecast period 2030. Fecal Microbiota Transplantation (FMT) Market has been defined as the transfer of distal gut microbial communities from a healthy individual to a patient’s intestinal tract to cure a disease. The report covers the current estimated and forecasted data for the Global Fecal Microbiota Transplantation Market on a global and regional level. The report provides an in-depth analysis of the Global Fecal Microbiota. Fecal Microbiota Transplantation Market for the period 2024 – 2030, wherein 2023 is the base year and the period from 2023 to 2029 is the forecast period. Data for 2018- 2022 has been included as historical information. The study provides a detailed perspective on market growth, throughout the above forecast period in terms of revenue estimates (in US$ MN), across the different geographies, which include North America (NA), Europe (EU), Asia Pacific (APAC), Middle East & Africa (MEA) and Latin America (LATAM).To know about the Research Methodology :- Request Free Sample Report The global fecal microbiota transplantation market is segmented by Disease Indication and Region. The report provides qualitative and quantitative insights on the fecal microbiota transplantation industry trends and a detailed analysis of the market size and growth rate of all segments in the market.
Fecal Microbiota Transplantation (FMT) Market Dynamics
Fecal Microbiota Transplantation has increasingly gained interest and rapid acceptance during the last decade. Data from several randomized clinical trials revealed that FMT is efficient and safe therapy from gastrointestinal diseases. As National institute of health states that, FMT clinically cured 91% of patients those are not treated by other medical therapy. This shows that the global fecal microbiota transplantation market has the huge scope in the applied medical sciences. Fecal microbiome has pathologic, diagnostic, and therapeutic implications in a spectrum of disorders from irritable bowel syndrome (IBS) to neuropsychiatric disease. FMT appears safe in immunocompromised patients including patients on biologic therapy, organ transplant recipients, and those with decompensated cirrhosis and end-stage kidney disease. As a result, the global fecal microbiota transplantation market has the lucrative opportunities in the forecast period.FFecal Microbiota Transplantation (FMT) Market Segment Analysis
By Disease Indication FMT treatment has been successfully used to treat recurrent Clostridium difficile infection (rCDI). The success of FMT in C. difficile disease led to investigations of its opportunities in the treatment of other gastrointestinal disorders. People from several countries are facing increasing incidence and severity of C. diffile and also reoccurrence of disease. The segment clostridium difficile contributes xx% in the global FMT market as well as provides wide opportunities for the growth of global market.Fecal Microbiota Transplantation (FMT) Market Regional Analysis
Europe is expected to commend the largest market share of xx% in the global fecal microbiota transplantation market. Clostridium difficile infection (CDI) has become the leading cause of nosocomial infection in the United States with significant risk of both morbidity and mortality. Data from the United States, suggests that approximately 20%–27% of all CDI cases are community associated, with an incidence of 20–30 per 100 000 population. The increased CDI incidence and severity during the recent years are creating broad scope for the advance research in the fecal microbiota transplantation. Program conduction in North America, regarding development of case specific clinical pipeline of fecal microbiota for various diseases, are acting as driving factor for global market. The objective of the report is to present a comprehensive analysis of the global fecal microbiota transplantation market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the global fecal microbiota transplantation market dynamics, structure by analysing the market segments and project global fecal microbiota transplantation market clear representation of competitive analysis of key players by price, financial position, by detection and equipment portfolio, growth strategies, and regional presence in the global fecal microbiota transplantation market make the report investor’s guide.Fecal Microbiota Transplantation (FMT) Market Scope: Inquire before buying
Fecal Microbiota Transplantation (FMT) Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US $ 1.31 Bn. Forecast Period 2024 to 2030 CAGR: 4.9% Market Size in 2030: US $ 1.83 Bn. Segments Covered: by Disease Indication Clostridium Difficile Infections Parkinsons Disease Obesity Diabetes Mellitus Autism Others Fecal Microbiota Transplantation (FMT) Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South AmericaFecal Microbiota Transplantation (FMT) Market, Key Players
1. Rebiotix Inc. 2. Finch Therapeutics 3. Seres Therapeutics 4. Crestovo LLC 5. MicroBiome Therapeutics LLC 6. Enterome Bioscience 7. MaaT Pharma 8. Rebiotix 9. Ritter Pharmaceuticals 10. Second Genome 11. OpenBiome Frequently Asked Questions: 1. Which region has the largest share in Global Fecal Microbiota Transplantation (FMT) Market? Ans: Europe region held the highest share in 2023. 2. What is the growth rate of Global Fecal Microbiota Transplantation (FMT) Market? Ans: The Global Fecal Microbiota Transplantation (FMT) Market is growing at a CAGR of 4.9% during forecasting period 2024-2030. 3. What is scope of the Global Fecal Microbiota Transplantation (FMT) Market report? Ans: Global Fecal Microbiota Transplantation (FMT) Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Fecal Microbiota Transplantation (FMT) Market? Ans: The important key players in the Global Fecal Microbiota Transplantation (FMT) Market are – Rebiotix Inc., Finch Therapeutics, Seres Therapeutics, Crestovo LLC, MicroBiome Therapeutics LLC, Enterome Bioscience, MaaT Pharma, Rebiotix, Ritter Pharmaceuticals, Second Genome, and OpenBiome. 5. What is the study period of this Market? Ans: The Global Fecal Microbiota Transplantation (FMT) Market is studied from 2023 to 2030.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Flow Cytometry Products Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2022 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Flow Cytometry Products Market 3.4. Geographical Snapshot of the Flow Cytometry Products Market, By Manufacturer share 4. Global Flow Cytometry Products Market Overview, 2023-2030 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Flow Cytometry Products Market 5. Supply Side and Demand Side Indicators 6. Global Flow Cytometry Products Market Analysis and Forecast, 2023-2030 6.1. Global Flow Cytometry Products Market Size & Y-o-Y Growth Analysis. 7. Global Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 7.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 7.1.1. Clostridium Difficile Infections 7.1.2. Parkinsons Disease 7.1.3. Obesity 7.1.4. Diabetes Mellitus 7.1.5. Autism 7.1.6. Others 8. Global Flow Cytometry Products Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2023-2030 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 9.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 9.1.1. Clostridium Difficile Infection 9.1.2. Parkinsons Disease 9.1.3. Obesity 9.1.4. Diabetes Mellitus 9.1.5. Autism 9.1.6. Others 10. North America Flow Cytometry Products Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2023-2030 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 11.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 12. Canada Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 12.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 13. Mexico Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 13.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 14. Europe Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 14.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 15. Europe Flow Cytometry Products Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2023-2030 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 16.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 17. France Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 17.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 18. Germany Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 18.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 19. Italy Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 19.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 20. Spain Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 20.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 21. Sweden Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 21.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 22. CIS Countries Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 22.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 23. Rest of Europe Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 23.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 24. Asia Pacific Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 24.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 25. Asia Pacific Flow Cytometry Products Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2023-2030 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 26.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 27. India Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 27.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 28. Japan Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 28.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 29. South Korea Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 29.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 30. Australia Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 30.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 31. ASEAN Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 31.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 32. Rest of Asia Pacific Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 32.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 33. Middle East Africa Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 33.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 34. Middle East Africa Flow Cytometry Products Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2023-2030 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 35.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 36. GCC Countries Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 36.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 37. Egypt Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 37.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 38. Nigeria Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 38.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 39. Rest of ME&A Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 39.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 40. South America Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 40.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 41. South America Flow Cytometry Products Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2023-2030 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 42.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 43. Argentina Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 43.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 44. Rest of South America Flow Cytometry Products Market Analysis and Forecasts, 2023-2030 44.1. Market Size (Value) Estimates & Forecast By Disease Indication, 2023-2030 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Flow Cytometry Products Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Rebiotix Inc 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Finch Therapeutics 45.3.3. Seres Therapeutics 45.3.4. Crestovo LLC 45.3.5. MicroBiome Therapeutics LLC 45.3.6. Enterome Bioscience 45.3.7. MaaT Pharma 45.3.8. Rebiotix 45.3.9. Ritter Pharmaceuticals 45.3.10. Second Genome 45.3.11. OpenBiome 46. Primary Key Insights